Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zhu C et al. – Repeated, low–dose, recombinant human erythropoietin treatment reduced the risk of disability for infants with moderate HIE, without apparent side effects.

Related Articles

Current concepts in the assessment and treatment of Hepatic Encephalopathy
QJM: An International Journal of Medicine, 11/12/09    Relevance Score: 88%

Screening of Infants for Hyperbilirubinemia to Prevent Chronic Bilirubin Encephalopathy: US Preventive Services Task Force Recommendation Statement
Pediatrics, 10/19/09    Relevance Score: 87%

Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09    Relevance Score: 85%

Systematic Review of Screening for Bilirubin Encephalopathy in Neonates
Pediatrics, 10/19/09    Relevance Score: 85%

Valproic acid-induced encephalopathy in very long course treated patients
Brain Injury, 10/22/09    Relevance Score: 84%

Today in Neuro/Psych pharmacology...keeping you current

Progesterone treatment for brain injury: an update
Future Neurology, 12/20/09

Cancer informatics for the clinician: An interaction database for chemotherapy regimens and antiepileptic drugs
Seizure - European Journal of Epilepsy, 12/20/09

Modafinil for multiple sclerosis fatigue: Does it work
Clinical Neurology and Neurosurgery, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address